ETC
Exchange Traded Concepts’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
3,940
+588
| +18% | +$309K | 0.03% | 460 |
|
|
2025
Q1 | $2.13M | Sell |
3,352
-2,807
| -46% | -$1.78M | 0.04% | 363 |
|
|
2024
Q4 | $4.39M | Buy |
6,159
+2,139
| +53% | +$1.52M | 0.09% | 216 |
|
|
2024
Q3 | $4.23M | Buy |
4,020
+107
| +3% | +$112K | 0.1% | 188 |
|
|
2024
Q2 | $4.11M | Buy |
3,913
+764
| +24% | +$803K | 0.1% | 190 |
|
|
2024
Q1 | $3.03M | Sell |
3,149
-1,805
| -36% | -$1.74M | 0.08% | 226 |
|
|
2023
Q4 | $4.35M | Buy |
4,954
+1,221
| +33% | +$1.07M | 0.12% | 173 |
|
|
2023
Q3 | $3.07M | Sell |
3,733
-459
| -11% | -$378K | 0.09% | 179 |
|
|
2023
Q2 | $3.01M | Sell |
4,192
-200
| -5% | -$144K | 0.07% | 215 |
|
|
2023
Q1 | $3.61M | Sell |
4,392
-2,993
| -41% | -$2.46M | 0.1% | 149 |
|
|
2022
Q4 | $5.33M | Buy |
7,385
+3,266
| +79% | +$2.36M | 0.15% | 110 |
|
|
2022
Q3 | $2.84M | Buy |
4,119
+408
| +11% | +$281K | 0.09% | 123 |
|
|
2022
Q2 | $2.19M | Sell |
3,711
-1,501
| -29% | -$887K | 0.06% | 158 |
|
|
2022
Q1 | $3.64M | Buy |
5,212
+667
| +15% | +$466K | 0.07% | 149 |
|
|
2021
Q4 | $2.87M | Sell |
4,545
-547
| -11% | -$345K | 0.06% | 204 |
|
|
2021
Q3 | $3.08M | Sell |
5,092
-1,742
| -25% | -$1.05M | 0.08% | 181 |
|
|
2021
Q2 | $3.82M | Sell |
6,834
-66
| -1% | -$36.9K | 0.12% | 123 |
|
|
2021
Q1 | $3.27M | Buy |
6,900
+2,957
| +75% | +$1.4M | 0.12% | 115 |
|
|
2020
Q4 | $1.91M | Buy |
3,943
+2,343
| +146% | +$1.13M | 0.09% | 152 |
|
|
2020
Q3 | $896K | Buy |
1,600
+498
| +45% | +$279K | 0.05% | 178 |
|
|
2020
Q2 | $687K | Buy |
1,102
+804
| +270% | +$501K | 0.11% | 146 |
|
|
2020
Q1 | $146K | Buy |
298
+64
| +27% | +$31.4K | 0.08% | 225 |
|
|
2019
Q4 | $88K | Buy |
+234
| New | +$88K | 0.02% | 212 |
|